NCT02590276View on ClinicalTrials.gov

Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 8, 2015

Primary Completion Date

October 27, 2020

Study Completion Date

October 27, 2020

Conditions
Frontotemporal Lobar DegenerationAmyotrophic Lateral Sclerosis
Interventions
BEHAVIORAL

characterization

Trial Locations (1)

75013

Groupe Hospitalier Pitié-Salpêtrière - Charles Foix, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02590276 - Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter